FMO5 and gastric cancer: The specific NADPH oxidase inhibitor ML171 and the known antioxidant NAC reduced ROS levels and inhibited lutein-induced increases in ROS levels, NF-κB activation, DNA fragmentation, and apoptotic cell death in gastric cancer AGS cells.